Broad-Spectrum Antibody for Safe Dengue Emergency Treatment
Anti-dengue Virus Antibody, Pharmaceutical Composition Comprising the Same, and Uses Thereof
Tags: National Cheng Kung University, Taiwan, Healthcare & Lifesciences
This technology introduces a monoclonal antibody, mAb 33D2, which can neutralize all four serotypes of the dengue virus. It works by preventing virus spread, reducing infectious particles, and blocking the virus-induced increase in vascular permeability. Unlike other antibodies, it does not cross-react with human proteins, reducing potential side effects. Applications include dengue emergency treatment and anti-viral therapies. Its broad-spectrum action makes it a promising therapeutic option.
IP Type or Form Factor: Patent Granted; Platform
TRL: Not specified
Industry or Tech Area: Pharmaceutical Engineering; Public Health & Universal Healthcare
